PMC:7594251 / 5783-6055 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T97004","span":{"begin":99,"end":102},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"nt literature (Figure 1). While scientific interest in NMR is still growing, the number of patents has been decreasing since the early 2000s. The top applicants of NMR in pharmaceutical patents are Bristol Myers, AstraZeneca, and Wyeth, with 146, 104, and 67 patent famili"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T34","span":{"begin":171,"end":185},"obj":"Chemical"}],"attributes":[{"id":"A34","pred":"chebi_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_52217"}],"text":"nt literature (Figure 1). While scientific interest in NMR is still growing, the number of patents has been decreasing since the early 2000s. The top applicants of NMR in pharmaceutical patents are Bristol Myers, AstraZeneca, and Wyeth, with 146, 104, and 67 patent famili"}

{"project":"LitCovid-sentences","denotations":[{"id":"T43","span":{"begin":26,"end":141},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nt literature (Figure 1). While scientific interest in NMR is still growing, the number of patents has been decreasing since the early 2000s. The top applicants of NMR in pharmaceutical patents are Bristol Myers, AstraZeneca, and Wyeth, with 146, 104, and 67 patent famili"}